cervidil 10mg vaginální inzert - search results

United States - English - NLM (National Library of Medicine)

cervidil- dinoprostone insert

ferring pharmaceuticals inc. - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 10 mg in 241 mg - cervidil is indicated for the initiation and/or continuation of cervical ripening in pregnant women at or near term in whom there is a medical or obstetrical indication for the induction of labor. cervidil is contraindicated in patients with: - known hypersensitivity to prostaglandins [see adverse reactions (6.2)] - evidence or clinical suspicion of fetal distress where delivery is not imminent - unexplained vaginal bleeding in the current pregnancy - evidence or clinical suspicion of marked cephalopelvic disproportion - conditions for which induction of labor is contraindicated - conditions for which oxytocic drugs are contraindicated - previous cesarean section or other uterine surgery expected to affect uterine integrity (such as myomectomy) - conditions under which prolonged contraction of the uterus may be detrimental to fetal safety - concurrent use with intravenous oxytocic agents [see warnings and precautions (5.4) and drug interactions (7)] - six or more previous term pregnancies risk summary cervidi

Ireland - English - HPRA (Health Products Regulatory Authority)

propess 10 mg vaginal delivery system

ferring ireland ltd - dinoprostone - vaginal delivery system - 10 milligram(s) - prostaglandins; dinoprostone

Australia - English - Department of Health (Therapeutic Goods Administration)

cervidil dinoprostone 10 mg pessary sachet

ferring pharmaceuticals pty ltd - dinoprostone, quantity: 10 mg - pessary - excipient ingredients: hexanetriol/macrogol 8000/isocyanate cross linked hydrogel copolymer - cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour.

New Zealand - English - Medsafe (Medicines Safety Authority)

cervidil

pharmaco (nz) ltd - dinoprostone 10mg; - pessary - 10 mg - active: dinoprostone 10mg excipient: hydrogel texturised polyester yarn retrieval system - cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour.

Australia - English - Department of Health (Therapeutic Goods Administration)

cervidil

csl limited - dinoprostone -